Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Other Non Operating Income (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Other Non Operating Income for 13 consecutive years, with -$6000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 101.26% to -$6000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$26000.0, a 103.19% decrease, with the full-year FY2025 number at -$26000.0, down 105.49% from a year prior.
  • Other Non Operating Income was -$6000.0 for Q4 2025 at Ekso Bionics Holdings, down from -$5000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.1 million in Q2 2021 to a low of -$2.4 million in Q4 2021.
  • A 5-year average of -$22789.5 and a median of -$5000.0 in 2025 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: plummeted 193.99% in 2021, then soared 1810.0% in 2024.
  • Ekso Bionics Holdings' Other Non Operating Income stood at -$2.4 million in 2021, then skyrocketed by 72.62% to -$655000.0 in 2022, then surged by 209.77% to $719000.0 in 2023, then plummeted by 33.8% to $476000.0 in 2024, then tumbled by 101.26% to -$6000.0 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Other Non Operating Income are -$6000.0 (Q4 2025), -$5000.0 (Q3 2025), and -$641000.0 (Q2 2025).